TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote April 2, 1976
TCL Archive Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models November 20, 1998